TA216 Leukaemia (lymphocytic) - bendamustine: Appendix B - proposal paper presented to the Institute's Guidance Executive
|
TA216 Leukaemia (lymphocytic) - bendamustine: Appendix B - proposal paper presented to the Institute's Guidance Executive
20 December 2013 (296.49 Kb 26 sec) |
This page was last updated: 20 December 2013